Abstract | BACKGROUND: METHODS: A luciferase reporter assay was used to analyze the interaction between MAGI2-AS3 and miR-374b-5p and between miR-374b-5p and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). SH-SY5Y and BV2 cells treated with Aβ25-35 were used to mimic neuronal injury and neuroinflammation in AD pathogenesis. Cell viability was evaluated using a MTT assay, and pro-inflammatory cytokine levels were measured using ELISA kits. MAGI2-AS3 and miR-374b-5p expression was examined using quantitative real-time PCR. RESULTS: BACE1 served as a target gene of miR-374b-5p, and MAGI2-AS3 could sponge miR-374b-5p. The expression of MAGI2-AS3 was increased, and miR-374b-5p was decreased in both SH-SY5Y and BV2 cells exposed to Aβ25-35. MAGI2-AS3 reduction enhanced neuronal viability and attenuated neuroinflammation in AD cell models, and miR-374b-5p overexpression led to same effects, but miR-374b-5p inhibition reversed these effects. Serum MAGI2-AS3 and miR-374b-5p levels in AD patients were negatively correlated and correlated with disease severity. CONCLUSION: The findings indicated that the MAGI2-AS3/miR-374b-5p axis regulates Aβ-induced neurotoxicity in SH-SY5Y cells and neuroinflammation in BV2 cells. The MAGI2-AS3/miR-374b-5p axis may provide novel biomarkers and therapeutic targets for AD.
|
Authors | Jingjing Zhang, Rui Wang |
Journal | Experimental gerontology
(Exp Gerontol)
Vol. 144
Pg. 111180
(02 2021)
ISSN: 1873-6815 [Electronic] England |
PMID | 33279663
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Adaptor Proteins, Signal Transducing
- MicroRNAs
- RNA, Long Noncoding
- Guanylate Kinases
- MAGI2 protein, human
- Amyloid Precursor Protein Secretases
- Aspartic Acid Endopeptidases
|
Topics |
- Adaptor Proteins, Signal Transducing
- Alzheimer Disease
(genetics)
- Amyloid Precursor Protein Secretases
(genetics)
- Aspartic Acid Endopeptidases
(genetics)
- Cell Line, Tumor
- Guanylate Kinases
- Humans
- MicroRNAs
(genetics)
- Neurodegenerative Diseases
- RNA, Long Noncoding
(genetics)
|